Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Organic Letters|December 31, 2010
First synthesis of C. difficile PS-II cell wall polysaccharide repeating unitElisa Danieli, Luigi Lay, Daniela Proietti, et al.
Glycoconjugate Journal|June 5, 2010
Preparation, characterization and immunogenicity of HIV-1 related high-mannose oligosaccharides-CRM197 glycoconjugatesAnna Kabanova, Roberto Adamo, Daniela Proietti, et al.
Chembiochem : a European Journal of Chemical Biology|March 12, 2014
Defined conjugation of glycans to the lysines of CRM197 guided by their reactivity mappingStefano Crotti, Huili Zhai, Jing Zhou, et al.
Vaccine|March 1, 2005
Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135Angela Bardotti, Giovanni Averani, Francesco Berti, et al.
Bioorganic & Medicinal Chemistry|September 25, 2012
Synthesis of Staphylococcus aureus type 5 capsular polysaccharide repeating unit using novel L-FucNAc and D-FucNAc synthons and immunochemical evaluationElisa Danieli, Daniela Proietti, Giulia Brogioni, et al.
Toxins|April 25, 2014
Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activityMaria R Romano, Rosanna Leuzzi, Emilia Cappelletti, et al.
The Journal of Biological Chemistry|February 11, 2015
Streptococcus agalactiae capsule polymer length and attachment is determined by the proteins CpsABCDChiara Toniolo, Evita Balducci, Maria Rosaria Romano, et al.
Vaccine|January 26, 2010
Beta-glucan-CRM197 conjugates as candidates antifungal vaccinesCarla Bromuro, Maria Romano, Paola Chiani, et al.
Carbohydrate Research|May 9, 2002
Isolation of oligosaccharides from a partial-acid hydrolysate of pneumococcal type 3 polysaccharide for use in conjugate vaccinesDirk J Lefeber, Ricardo Gutiérrez Gallego, Christian H Grün, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 9, 2016
The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccineAgnese Donadei, Cristiana Balocchi, Francesca Mancini, et al.
Pageof 3